Structure Therapeutics Inc. News

Latest updates and market news for GPCR

8 news

Mar 16 - Mar 22, 2026

Page 1

Eli Lilly Confirms 'Superior Weight Loss' Of Its Next-Generation Obesity Drug

Investor's Business Daily

2 days ago

Eli Lilly Confirms 'Superior Weight Loss' Of Its Next-Generation Obesity Drug

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?

Zacks

4 days ago

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?

Structure Therapeutics Posts 15%+ Weight Loss in ACCESS II for Oral GLP-1 Aleniglipron, Eyes Phase III

MarketBeat

4 days ago

Structure Therapeutics Posts 15%+ Weight Loss in ACCESS II for Oral GLP-1 Aleniglipron, Eyes Phase III

Rival GLP-1 pill matches Wegovy weight loss data, adding to competitive pressure on Novo Nordisk

Proactive

5 days ago

Rival GLP-1 pill matches Wegovy weight loss data, adding to competitive pressure on Novo Nordisk

These Stocks Are Today’s Movers: Nvidia, Nebius, Meta, Micron, Strategy, Structure Therapeutics, Dollar Tree, and More

Barrons.com

5 days ago

These Stocks Are Today’s Movers: Nvidia, Nebius, Meta, Micron, Strategy, Structure Therapeutics, Dollar Tree, and More

Structure Therapeutics Pops; But Can It Take On Lilly's Looming Obesity Pill?

Investor's Business Daily

5 days ago

Structure Therapeutics Pops; But Can It Take On Lilly's Looming Obesity Pill?

A New GLP-1 Pill Melted Away the Pounds. Is Structure Therapeutics a Takeover Candidate?

Barrons.com

5 days ago

A New GLP-1 Pill Melted Away the Pounds. Is Structure Therapeutics a Takeover Candidate?

📈

AI Sentiment

Highly Positive

9/10

MT Newswires

6 days ago

Structure Therapeutics Says Aleniglipron Reduces Weight in Phase 2, Extension Studies

Share this news page

Share on Social Networks: